Our RESETTM clinical trials with rese-cel (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/14/26 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
  |
112 |
| 11/10/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
114 |
| 08/07/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
159 |
| 05/15/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
 |
107 |
| 11/14/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
139 |
| 08/08/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
113 |
| 05/15/24 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
110 |
| 11/09/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
116 |
| 08/10/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
114 |
| 05/11/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
127 |
